Emmanuel Kwaku Ofori

Emmanuel Kwaku Ofori

Auto-generated profile, based on publicly available information

Emmanuel Kwaku Ofori

Department of Chemical Pathology, University of Ghana Medical School, Accra, Ghana

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2016 in Reproductive Health
Verified
Journal Article
Open access
PDF file
HAH. Asare-Anane
H. Asare-Anane
SBS. B. Bannison
S. B. Bannison
EOEmmanuel K. Ofori
Emmanuel K. Ofori
RAR. O. Ateko
R. O. Ateko
ABA. T. Bawah
A. T. Bawah
JZJ. B. Ziem
J. B. Ziem
Tobacco smoking is a public health issue and has been implicated in adverse reproductive outcomes including semen quality. Available data however provides conflicting findings. The objective of this study was to evaluate the effect of tobacco smoking on semen quality among men in Ghana. In this study, a total of 140 subjects were recruited, comprising 95 smokers and 45 non-smokers. Smokers were further categorized into mild, moderate and heavy smokers. Semen parameters such as sperm concentration, motility, viability and normal morphology were measured according to the World Health Organisation criteria. The study showed that smokers had significantly lower semen volume, sperm concentration, sperm motility, total sperm count, sperm morphology, free testosterone and follicle stimulating hormone (p <0.05 respectively), compared with non-smokers. Smokers were at a higher risk of developing oligospermia, asthenozoospermia and teratozoospermia (OR = 3.1, 4.2 and, 4.7; p <0.05) than non-smokers. Results demonstrated a decline in semen quality in a dose dependent tobacco smoking manner.

23 March 2023 in Endocrinology, Diabetes & Metabolism
Verified
Journal Article
Open access
EOEmmanuel K. Ofori
Emmanuel K. Ofori
ABAlfred Buabeng
Alfred Buabeng
SASeth D. Amanquah
Seth D. Amanquah
KDKwabena O. Danquah
Kwabena O. Danquah
SASeth K. Amponsah
Seth K. Amponsah
HAHenry Asare‐Anane
Henry Asare‐Anane
Introduction: Insulin resistance (IR) is one of the common chronic metabolic disorders in Africa and elsewhere. Accumulation of lipids in the body may be due to an imbalance in the metabolism of lipids, glucose and proteins. Ceramides are a sphingolipid class of lipids that are biologically active and vital in the production of more complex lipids. Circulating ceramides are thought to have a role in the development of obesity‐related IR, although the precise involvement remains unclear.Aim: To investigate the impact of circulating ceramide on IR and body adiposity in people with and without type 2 diabetes mellitus (T2DM).Methodology: The study was observational and cross‐sectional. There were a total of 84 volunteers with T2DM and 75 nondiabetics (control). The participants' ages, body mass indexes (BMI), waist circumferences, and blood pressure (BP) were among the clinical parameters assessed. Ceramide levels, fasting plasma glucose (FPG), lipids, basal insulin levels and glycated haemoglobin (HbA1c) were also measured. Additionally, the homeostatic model assessment for IR (HOMA‐IR) and beta cell function (HOMA‐β) were computed.Results: T2DM and control participants had different mean values for anthropometric parameters, BP, FPG, HbA1c, lipids, insulin, HOMA‐IR, HOMA‐β and ceramide levels (p < .05 for all). HOMA‐IR, HOMA‐β and cardiovascular risk were significant correlates with ceramide levels in the T2DM group (r = 0.24; −0.34; 0.24, p < .05, respectively). Further, FPG (OR = 1.83, p = .01) and ceramide (OR = 1.05, p = .01) levels were significant predictors of IR in the case group.Conclusion: Patients with T2DM exhibited high ceramide concentrations, which, when combined with high FPG, were associated with IR. The consequences of circulating ceramides in health and disease; however, merit further research.

1 January 2025 in Journal of Nanotechnology
Verified
Journal Article
Open access
IAIsmaila Adams
Ismaila Adams
OAOfosua Adi-Dako
Ofosua Adi-Dako
RARegina Appiah-Opong
Regina Appiah-Opong
EOEbenezer Ofori-Attah
Ebenezer Ofori-Attah
AAAbigail Aning
Abigail Aning
SASeth Kwabena Amponsah
Seth Kwabena Amponsah
Purpose: This study presents a novel and sustainable approach to cancer therapy by combining halloysite nanotubes (HNTs), green‐synthesized copper oxide (CuO) nanoparticles, and curcumin (CUR). We demonstrate that the green synthesis of CuO nanoparticles, when combined with CUR and incorporated into HNTs, enhances the delivery and anticancer effects of CUR. This innovative complex could address some of the critical limitations of current anticancer therapies such as poor pharmacokinetics and drug resistance by providing a controlled release mechanism and leveraging the benefits of combination therapy. Methods: We synthesized CuO using green synthesis with lemon peel extract and used this synthesized CuO to formulate a complex with HNT and CUR (CHC). Comprehensive characterization was conducted using UV‐visible spectroscopy, scanning electron microscopy‐energy‐dispersive X‐ray spectroscopy (SEM–EDX), X‐ray diffraction (XRD), thermogravimetric analysis (TGA), and Fourier‐transform infrared spectroscopy (FTIR). We also examined the release kinetics of the formulation. In vitro experiments were performed to evaluate the anticancer effects of the complex on HMVII, HepG2, and MCF‐7 cancer cell lines. In addition, an in silico docking assessment and a 10 ns molecular dynamics simulation were conducted to determine the interaction between CUR and HNTs. Results: The characterization of HNTs loaded with CUR showed a drug loading efficiency of 3%–5% and an encapsulation efficiency of 15%–20%. Drug release kinetics were best described by the Hixson–Crowell model for CHC‐50 and CHC‐20, with R 2 = 0.9897 and R 2 = 0.9900 respectively. CHC‐10 fit the Higuchi model ( R 2 = 0.8838), while free CUR fit the Korsmeyer–Peppas model ( R 2 = 0.9212). The formulations demonstrated significant anticancer effects across all tested cell lines, with CHC‐10 showing the lowest IC 50 value of 10.43 μg/mL. The CHC formulations exhibited enhanced delivery and maintained significant anticancer activity compared to CUR across HepG2, MCF‐7, and HMVII cell lines, with lower IC50 values after UV exposure. Molecular docking analysis revealed a CUR–HNT binding score of −3.803, with the complex remaining stable over a 10 ns simulation. Conclusion: This study demonstrates the successful integration of green‐synthesized CuO nanoparticles with CUR‐loaded HNTs as a novel approach to cancer therapy. The enhanced anticancer effects of the CHC‐10 formulation, coupled with the complex’s stability, suggest significant potential for improving cancer treatment outcomes. This innovative, sustainable approach addresses key limitations of current therapies, potentially offering more effective and patient‐friendly treatments with reduced side effects. Our findings pave the way for further development of targeted, environmentally conscious cancer therapies.

9 August 2016 in Disease Markers
Verified
Journal Article
Open access
PDF file
HAHenry Asare-Anane
Henry Asare-Anane
FTFelix Twum
Felix Twum
EOEmmanuel Kwaku Ofori
Emmanuel Kwaku Ofori
ETErving L. Torgbor
Erving L. Torgbor
SASeth D. Amanquah
Seth D. Amanquah
COCharlotte Osafo
Charlotte Osafo
Renal tubular lysosomal enzyme activities like alanine aminopeptidase (AAP) and N-acetyl-β-D-glucosaminidase (NAG) have been shown to increase in patients developing diabetic nephropathy and nephrosclerosis. This study aimed to determine the activities of N-acetyl-β-D-glucosaminidase and alanine aminopeptidase and albumin concentration in urine samples of patients with type 2 diabetes. One hundred and thirty (65 type 2 diabetic and 65 nondiabetic) subjects participated in this study. Blood samples were drawn for measurements of fasting blood glucose, albumin (Alb), lipids, and creatinine (Cr). Early morning spot urine samples were also collected for activities of alanine aminopeptidase (AAP), N-acetyl-β-D-glucosaminidase (NAG), and concentration of albumin (U-Alb) and creatinine (U-Cr). Both NAG/Cr and AAP/Cr were significantly increased in diabetic subjects compared to controls (p<0.001). There was positive correlation between NAG/Cr and Alb/Cr (r=0.49,p<0.001) and between NAG/Cr and serum creatinine (r=0.441,p<0.001). A negative correlation was found between NAG/Cr and eGFR (r=-0.432,p<0.05). 9.3% and 12% of diabetics with normoalbuminuria had elevated levels of AAP/Cr and NAG/Cr, respectively. We conclude that measuring the urinary enzymes activities (NAG/Cr and AAP/Cr) could be useful as a biomarker of early renal involvement in diabetic complications.

3 April 2019 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
EOEmmanuel Kwaku Ofori
Emmanuel Kwaku Ofori
DODorcas Owusu-Ababio
Dorcas Owusu-Ababio
ETEmmanuel A. Tagoe
Emmanuel A. Tagoe
HAHenry Asare-Anane
Henry Asare-Anane
This study aimed to evaluate dyslipidemia in Ghanaian subjects with type 2 diabetes. Hundred individuals with type 2 diabetes and 61 apparently healthy controls participated. The prevalence of hypercholesterolemia among persons with type 2 diabetes was 53%. Blood pressure, fasting blood glucose (FBG), triglyceride (TG), low-density lipoproteins (LDL) and alanine transaminase (ALT) levels were higher in persons with type 2 diabetes compared with the control group (p < 0.01). Positive correlations were found within persons with type 2 diabetes for triglyceride vs FBG; ALT vs age and aspartate transaminase (AST) vs TG (p < 0.05 respectively). This study demonstrated hyperlipidemia and poor liver health in persons with type 2 diabetes.

26 October 2022
Verified
Book Chapter
Closed access
PDF file
EOEmmanuel Kwaku Ofori
Emmanuel Kwaku Ofori